M-053

N/A

Report date: 2023/02/19 23:42:28

Base Information

Drug NameM-053
Drug Alias NameM-053
ClassificationCell and gene therapy > Gene therapy
Mechanisms of Actionα-Galactosidase replacementsGene transference
Targetsα-Galactosidase
Therapy Area/IndicationsFabry Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesM6P Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesM6P Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsFabry Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A